ask="16.75"
ask_size="100"
average_daily_volume="128857"
bid="4.15"
bid_size="100"
book_value="0.00"
change="-0.28"
change_from_200_day_moving_average="5.84"
change_from_50_day_moving_average="0.54"
change_from_52_week_high="-2.70"
change_From_52_week_low="5.00"
change_in_percent="-2.46%"
close="11.10"
dividend_pay_date="6/27/2013"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-1.55"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="11.67"
high_52_weeks="13.80"
last_trade_date="3/15/2017"
last_trade_price="11.10"
last_trade_size="1200"
last_trade_time="4:00pm"
low="10.30"
low_52_weeks="6.10"
market_capitalization="N/A"
moving_average_200_day="5.26"
moving_average_50_day="10.56"
name="Novelion Therapeutics Inc. "
notes="N/A"
one_year_target_price="10.00"
open="10.60"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+111.13%"
percent_change_from_50_day_moving_average="+5.12%"
percent_change_from_52_week_high="-19.57%"
percent_change_from_52_week_low="+81.97%"
previous_close="11.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="185240"
weeks_range_52="6.10 - 13.80"
